Effect of Blood Glucose Level of Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease on the Hypercoagulability and Thromboembolism
Qing Cao1, Wei Jiao2, Huihui Lu1, Jing Zhang2, Meiling Ren3, Yan Xu1* and Shuyang Hu1*
1Department of Nephroendocrinology, 904 Hospital of Joint Logistic Support Force of PLA, No. 101, Xingyuan North Road, Liangxi District, Wuxi, Jiangsu 214000, China
2Department of Nursing, 904 Hospital of Joint Logistic Support Force of PLA, No. 101, Xingyuan North Road, Liangxi District, Wuxi, Jiangsu 214000, China
3Department of Pediatrics, 904 Hospital of Joint Logistic Support Force of PLA, No. 101, Xingyuan North Road, Liangxi District, Wuxi, Jiangsu 214000, China
Qing Cao and Wei Jiao contributed equally to this work.
Fig. 2.
Effect of blood glucose level of patients on hypercoagulability. A, prothrombin time (PT); B, activated partial thromboplastin time (APTT); C, D-dimers (D-D); D, fibrinogen (Fb).
Fig. 3.
Effect of blood glucose level of patients on platelet functions. A, P-selectin (Ps); B, thrombus precursor protein (TpP); C, maximum platelet aggregation rate (MAR); D, mean platelet volume (MPV).
Fig. 4.
Effect of blood glucose level of patients on thromboembolism.
Fig. 1.
Effect of blood glucose level of patients on hypercoagulability. A, fasting blood glucose (FBG); B, 2 h postprandial glucose (2hPG); C, glycosylated hemoglobin (HbA1c); D, fasting insulin (FINS).
Fig. 5.
Effect of blood glucose level of patients on Survival of patients in 2-year follow-up.